CVS Health Corporation

Equities

CVS

US1266501006

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-07-10 pm EDT 5-day change 1st Jan Change
57.53 USD -0.16% Intraday chart for CVS Health Corporation +0.02% -27.14%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Walgreens Boots Alliance, Inc. Appoints William H. Shrank to Board of Directors CI
Sector Update: Health Care Stocks Higher Late Afternoon MT
Sector Update: Health Care MT
FTC to Sue Pharmacy Benefit Managers Over Drug Prices MT
FTC to Sue Pharmacy Benefit Managers Over Insulin Prices MT
FTC to Sue Pharmacy Benefit Managers Over Insulin Prices, Wall Street Journal Reports MT
US FTC to sue drug middlemen over insulin prices, WSJ reports RE
US FTC Report Says Pharmacy Benefit Managers Contribute to Higher Drug Costs MT
Sector Update: Health Care Stocks Mixed Late Afternoon MT
Sector Update: Health Care Stocks Rise in Afternoon Trading MT
Sector Update: Health Care MT
US FTC Report Says Pharmacy Benefit Managers Contribute to Higher Drug Costs MT
Chip stocks, megacaps steer S&P 500, Nasdaq to record highs RE
Middlemen have outsized influence on US drug prices due to market consolidation, FTC says RE
CVS Health Keeps Quarterly Dividend at $0.665 per Share; Payable Aug. 1 to Shareholders as of July 22 MT
CVS Health Announces Quarterly Dividend, Payable on August 1, 2024 CI
CVS Health Corporation(NYSE:CVS) dropped from Russell 1000 Value-Defensive Index CI
CVS Health Corporation(NYSE:CVS) dropped from Russell 1000 Defensive Index CI
Walgreens cuts 2024 profit forecast, announces store closures RE
Walgreens cuts 2024 profit forecast on worse-than-expected consumer spending RE
Rate of US uninsured to rise to 8.9% in the next decade, Congressional Budget Office says RE
Amazon Pharmacy expands $5 monthly subscription to Medicare patients RE
Barclays Adjusts Price Target on CVS Health to $65 From $63 MT
CMS to rework quality ratings for Medicare Advantage plans RE
Wolfe Research Adjusts Price Target on CVS Health to $64 From $70, Keeps Outperform Rating MT
Chart CVS Health Corporation
More charts
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
57.62 USD
Average target price
69.1 USD
Spread / Average Target
+19.92%
Consensus
  1. Stock Market
  2. Equities
  3. CVS Stock
  4. News CVS Health Corporation
  5. FTC to Sue Pharmacy Benefit Managers Over Drug Prices